Rubicon Research Limited (BOM:544578)
India · Delayed Price · Currency is INR 1,360.00
+61.70 (4.75%)
At close: Jun 19, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 226.8 billion as of June 22, 2026.
Market Cap
226.80B
Enterprise Value
226.45B
Revenue
17.54B
Ranking
n/a
PE Ratio
91.92
Stock Price
1,360.00
Market Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 226.80B, an increase of 119.13%. That is a compound annual growth rate of 215.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 226.80B | 102.22% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 557.17B |
| GlaxoSmithKline Pharmaceuticals | 395.20B |
| J. B. Chemicals & Pharmaceuticals | 351.51B |
| Rubicon Research | 224.36B |
| AstraZeneca Pharma India | 210.17B |
| Granules India | 194.73B |
| Caplin Point Laboratories | 190.50B |
| Jubilant Pharmova | 152.96B |